[Recent advances in diagnosis and management of atrial fibrillation]

N Y Mironov1, L Y Laiovich1, E S Mironova1

  • 1National Medical Research Center in Cardiology.

Terapevticheskii Arkhiv
|December 6, 2022
PubMed

Insights

Atrial fibrillation (AF) is a common heart rhythm disorder affecting 1-2% of the population. This review details the latest diagnostic and treatment strategies for AF, including novel drug and non-drug therapies.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Clinical Research

Context:

  • Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia, affecting 1-2% of the global population.
  • AF incidence is rising, with projections indicating a doubling of patient numbers within 50 years.
  • Cardiac rhythm disturbances are frequent clinical events, often stemming from various heart conditions.

Purpose:

  • To present the most current diagnostic approaches for atrial fibrillation.
  • To review contemporary non-drug and pharmaceutical treatment modalities for AF.
  • To highlight novel antiarrhythmic drugs and therapeutic strategies developed and implemented at the NMRC of Cardiology.

Summary:

  • This review synthesizes recent advancements in AF diagnosis and management.
  • It covers both established and innovative treatment options, including unique domestic antiarrhythmic drugs.
  • Non-drug interventions and their clinical implementation at the NMRC of Cardiology are also discussed.

Impact:

  • Provides clinicians with up-to-date information on AF management.
  • Facilitates the adoption of novel diagnostic and therapeutic strategies for AF.
  • Contributes to improved patient outcomes through evidence-based treatment recommendations.

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
28
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
75
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
32
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
16
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
45
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
25